Quest Diagnostics Inc Insider Trading
Every director, officer and 10% holder of Quest Diagnostics Inc has to report each trade in its stock within two business days of making it. This is those filings.
DGX on carbonthat →Purchases and sales
Open-market trades only — the lines where someone chose to buy or sell at the going price.
| Insider | Action | Value |
|---|---|---|
| J. E. DavisCEO and President2026-09-0110K shat $242.72 | Sale10b5-1 plan | $2.4M |
| Michael E PrevoznikSVP & General Counsel2026-08-2816K shat $242.88 | Sale10b5-1 plan | $3.9M |
| Michael E PrevoznikSVP & General Counsel2026-08-286.2K shat $243.63 | Sale10b5-1 plan | $1.5M |
| Michael E PrevoznikSVP & General Counsel2026-08-28430 shat $244.51 | Sale10b5-1 plan | $105.1K |
| Mark E DelaneySVP & Chief Commercial Officer2026-07-281.6K shat $235.18 | Sale10b5-1 plan | $376.3K |
Source: SEC Form 4 filings, via EDGAR. A derivative line reports the shares underlying an option rather than stock outstanding, so it is marked and is not comparable with the rest. Value is shares times the reported price, and is blank where the filing priced the transaction at zero — a grant costs its recipient nothing. Insiders sell for reasons that have nothing to do with the company, which is why a sale is not read as a signal on its own.
More on DGX
Follow Quest Diagnostics Inc (DGX) by email
New trades in Quest Diagnostics Inc (DGX) by members of Congress, insiders and funds, with the rest of the week's filings. One email a week, free.
Unsubscribe with one click from any email.